Natera and Eledon Announce Strategic Partnership for Prospera(TM) Monitoring in Planned Phase 3 Kidney Transplant Trial
June 25, 2026
Acasti Pharma Announces Initiation of Pharmacokinetic Study for GTX-102, the Company’s Drug Candidate for the Treatment of Ataxia Telangiectasia
September 13, 2022
Related Post
-
-
Onconetix Highlights Realbotix’s Launch of Humanoid Robot and AI Teachers Assistant Pilot Program in New York State School District
June 24, 2026
-
CEL-SCI and Saudi Amarox Hold Strategic Agreement Signing Ceremony at BIO 2026, Advancing U.S.-Saudi Cooperation in Cancer Care
June 24, 2026
-
Capstone Extends Credit Facilities with Beacon Bank and Stream Finance on Identical Terms
June 22, 2026